Better Therapeutics, Inc. (BTTX) Earnings Per Share, Diluted USD/shares 2021 - 2023

Historical data

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Better Therapeutics, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from 2021 to 2023.
  • Better Therapeutics, Inc. Earnings Per Share, Diluted for the quarter ending September 30, 2023 was -0.15 USD/shares, a 68.8% increase year-over-year.
  • Better Therapeutics, Inc. Earnings Per Share, Diluted for the twelve months ending September 30, 2023 was -1.16 USD/shares.
  • Better Therapeutics, Inc. annual Earnings Per Share, Diluted for 2022 was -1.69 USD/shares, a 45.7% increase from 2021.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly Data (USD/shares)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$1 $0 +$0.33 +68.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$1 $0 +$0.18 +42.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 -$2 $0 +$0.02 +4.88% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$2 $0 Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 $0 +$0.72 +60% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $0 +$0.42 +50% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 -$1 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.